Skip to content

Zymeworks ZYME Number of operating segments

Number of operating segments at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
0.3
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
10.0%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:NumberOfOperatingSegments.

The official record: Zymeworks’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's number of operating segments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's number of operating segments?
Zymeworks (ZYME) reported number of operating segments of 0.3 in Q4 2025.
What does number of operating segments mean?
Indicates the count of distinct business components for which separate financial information is evaluated regularly by the chief operating decision maker. This metric reflects the organizational complexity and the diversification of the company's business model. It provides context for how management allocates resources across different product lines or geographies.